[Antiplatelet drugs as a means of augmentation efficacy and safety of percutaneous coronary interventions in patients with ischemic heart disease]

Kardiologiia. 2003;43(11):66-75.
[Article in Russian]
No abstract available

Publication types

  • Review

MeSH terms

  • Angioplasty, Balloon, Coronary / adverse effects*
  • Coronary Thrombosis / prevention & control*
  • Humans
  • Myocardial Ischemia / therapy*
  • Platelet Aggregation Inhibitors / therapeutic use*
  • Randomized Controlled Trials as Topic

Substances

  • Platelet Aggregation Inhibitors